Loading...

Company Profile: Gilead Sciences (NASDAQ:GILD)

1,413 views

Loading...

Loading...

Transcript

The interactive transcript could not be loaded.

Loading...

Loading...

Rating is available when the video has been rented.
This feature is not available right now. Please try again later.
Published on Apr 26, 2010

The company's HIV franchise includes blockbuster Truvada, a combination of two of its other drugs, Viread and Emtriva. It co-promotes another HIV treatment, called Atripla, in the US and Europe with Bristol-Myers Squibb. Other products on the market include AmBisome, used to treat systemic fungal infections such as those that accompany AIDS; Vistide, for AIDS-related eye infections; and hepatitis B antiviral Hepsera. Outside of the infectious disease realm, Gilead markets Letairis, a treatment for pulmonary arterial hypertension (PAH), or high pulmonary blood pressure.

Loading...

When autoplay is enabled, a suggested video will automatically play next.

Up next


to add this to Watch Later

Add to

Loading playlists...